[Federal Register Volume 74, Number 158 (Tuesday, August 18, 2009)]
[Notices]
[Pages 41711-41712]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-19778]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0247]


Food and Drug Administration Transparency Task Force; Reopening 
of Comment Period

AGENCY: Food and Drug Administration, HHS.

[[Page 41712]]


ACTION: Notice; reopening of comment period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is reopening until 
November 6, 2009, the comment period for the notice of public meeting 
and request for comments that appeared in the Federal Register of June 
3, 2009 (74 FR 26712). In the notice of public meeting and request for 
comments, FDA's Transparency Task Force requested comments on ways in 
which FDA can make useful and understandable information about FDA 
activities and decision making more readily available to the public. 
The agency is taking this action because the agency is planning a 
second public meeting this fall and is reopening the comment period to 
allow interested persons additional time to submit comments.

DATES: Submit written or electronic comments by November 6, 2009.

ADDRESSES: Submit written comments to the Division of Dockets 
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, 
rm. 1061, Rockville, MD 20852. Submit electronic comments to http://www.regulations.gov. All such comments should be identified with the 
docket number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Afia Asamoah, Office of the 
Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., 
Bldg. 1, rm. 2208, Silver Spring, MD 20993, 301-796-4625, FAX: 301-847-
3531, e-mail: <a href="/cdn-cgi/l/email-protection#86c7e0efe7a8c7f5e7ebe9e7eec6e0e2e7a8eeeef5a8e1e9f0"><span class="__cf_email__" data-cfemail="7c3d1a151d523d0f1d11131d143c1a181d5214140f521b130a">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: In the Federal Register of June 3, 2009 (74 
FR 26712), FDA published a notice of public meeting and request for 
comments on ways in which FDA can make useful and understandable 
information about FDA activities and decisionmaking more readily 
available to the public, in a manner compatible with the agency's goal 
of protecting confidential information, as appropriate. Interested 
persons were given until August 7, 2009, to submit comments. The agency 
is planning to hold a second meeting in the fall of 2009 about these 
issues and is reopening the comment period until November 6, 2009. FDA 
has also established an online blog at http://fdatransparencyblog.fda.gov in which interested persons may provide 
feedback on specific topics. The blog is expected to run through 
November 2009.
    Interested persons may submit written or electronic comments to the 
Division of Dockets Management (see ADDRESSES). Submit a single copy of 
electronic comments to http://www.reguations.gov or two paper copies of 
any mailed comments, except that individuals may submit one paper copy. 
Comments are to be identified with the docket number found in brackets 
in the heading of this document. Received comments may be seen in the 
Division of Dockets Management between 9 a.m. and 4 p.m., Monday 
through Friday.

    Dated: August 12, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E9-19778 Filed 8-17-09; 8:45 am]
BILLING CODE 4160-01-S


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>